ロード中...
Obstacles to early treatment of idiopathic pulmonary fibrosis: current perspectives
Idiopathic pulmonary fibrosis is a progressive and fatal fibrotic lung disease which has seen new opportunity for drug treatment in the last several years with the approval of nintedanib and pirfenidone, two antifibrotic agents aimed at slowing decline in lung function as defined by FVC on pulmonary...
保存先:
| 出版年: | Ther Clin Risk Manag |
|---|---|
| 主要な著者: | , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Dove Medical Press
2019
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6322512/ https://ncbi.nlm.nih.gov/pubmed/30655671 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/TCRM.S160248 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|